{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:09:32Z","timestamp":1792202972220,"version":"4.4.0"},"reference-count":116,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0378-6323.191134","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T10:35:45Z","timestamp":1474886145000},"page":"603","source":"Crossref","is-referenced-by-count":94,"title":["Guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: An Indian perspective"],"prefix":"10.25259","volume":"82","author":[{"given":"LalitKumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbhayMani","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidheesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschal","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NilayKanti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuvel","family":"Kumaresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.191134-1","first-page":"92","volume-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-2","first-page":"28S","volume-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.191134-3","first-page":"803","volume-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"key-10.4103\/0378-6323.191134-4","first-page":"35","volume-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs.The EuroSCAR-study","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.191134-5","first-page":"131","volume-title":"Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic","author":"Wetter","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0378-6323.191134-6","first-page":"998","volume-title":"A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","author":"Ferrandiz-Pulido","year":"2013","journal-title":"Arch Dis Child"},{"key":"key-10.4103\/0378-6323.191134-7","first-page":"59","volume-title":"Recent advances of pharmacogenomics in severe cutaneous adverse reactions: Immune and nonimmune mechanisms","author":"Dao","year":"2015","journal-title":"Asia Pac Allergy"},{"key":"key-10.4103\/0378-6323.191134-8","first-page":"579","volume-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-9","first-page":"1126","volume-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.191134-10","first-page":"118","volume-title":"Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis","author":"Somkrua","year":"2011","journal-title":"BMC Med Genet"},{"key":"key-10.4103\/0378-6323.191134-11","first-page":"49","volume-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: An observational, retrospective case series study","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0378-6323.191134-12","first-page":"1343","volume-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"key-10.4103\/0378-6323.191134-13","first-page":"187","volume-title":"Toxic epidermal necrolysis: Part II.Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-14","unstructured":"Sharma VK, Jerajani HR, Srinivas CR, Valia A, Khandpur S. IADVL Consensus Guidelines 2006: Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. In: Sharma VK, editor. Guidelines for vitiligo, Stevens-Johnson syndrome, toxic epidermal necrolysis and psoriasis. 2nd ed. New Delhi: IADVL's Therapeutic Guidelines Committee; 2008."},{"key":"key-10.4103\/0378-6323.191134-15","first-page":"173","volume-title":"Toxic epidermal necrolysis: Part I.Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-16","first-page":"458","volume-title":"Management of toxic epidermal necrolysis","author":"Pasricha","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-17","first-page":"149","volume-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.191134-18","first-page":"111","volume-title":"Simplifying the language of evidence to improve patient care: Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in medical literature","author":"Ebell","year":"2004","journal-title":"J Fam Pract"},{"key":"key-10.4103\/0378-6323.191134-19","first-page":"323","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-20","first-page":"1156","volume-title":"Treatment of toxic epidermal necrolysis.Cr\u00e9teil's experience","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-21","first-page":"e119","volume-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","author":"Creamer","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key-10.4103\/0378-6323.191134-22","first-page":"379","volume-title":"Acute skin failure: Concept, causes, consequences and care","author":"Inamadar","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-23","first-page":"6","volume-title":"Epidemiology","author":"Committee","year":"2003","journal-title":"Indian J Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/0972-5229","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-24","unstructured":"Roujeau JC, Revuz J. Intensive care in dermatology. In: Champion RH, Pye RJ, editors. Recent Advances in Dermatology. Edinburg: Churchill Livingstone; 1990. p. 85-99."},{"key":"key-10.4103\/0378-6323.191134-25","first-page":"250","volume-title":"Role of blood transfusion in the management of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)","author":"Dhar","year":"1998","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-26","first-page":"331","volume-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"key-10.4103\/0378-6323.191134-27","first-page":"149","volume-title":"Fifteen cases of toxic epidermal necrolysis (Lyell)","author":"Bj\u00f6rnberg","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.191134-28","first-page":"204","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson's disease","author":"Ohlenschlaeger","year":"1966","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.191134-29","first-page":"178","volume-title":"Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis.Report of a patient treated with corticosteroid \u201cpulse therapy\u201d","author":"Sherertz","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-30","first-page":"881","volume-title":"Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","author":"Prendiville","year":"1989","journal-title":"J Pediatr"},{"key":"key-10.4103\/0378-6323.191134-31","first-page":"124","volume-title":"Management of nonstaphylococcal toxic epidermal necrolysis: Follow-up study of 16 case histories","author":"Tegelberg-Stassen","year":"1990","journal-title":"Dermatologica"},{"key":"key-10.4103\/0378-6323.191134-32","first-page":"89","volume-title":"Stevens-Johnson syndrome (SJS): Effectiveness of corticosteroids in management and recurrent SJS","author":"Patterson","year":"1992","journal-title":"Allergy Proc"},{"key":"key-10.4103\/0378-6323.191134-33","first-page":"151","volume-title":"The outcome of Stevens-Johnson syndrome treated with corticosteroids","author":"Cheriyan","year":"1995","journal-title":"Allergy Proc"},{"key":"key-10.4103\/0378-6323.191134-34","first-page":"33","volume-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-35","first-page":"335","volume-title":"Corticosteroids in Stevens-Johnson syndrome\/toxic epidermal necrolysis: Current evidence and implications for future research","author":"Law","year":"2015","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0378-6323.191134-36","first-page":"199","volume-title":"A 10-year experience with toxic epidermal necrolysis","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"key":"key-10.4103\/0378-6323.191134-37","first-page":"497","volume-title":"Toxic epidermal necrolysis: Analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients","author":"Kim","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.191134-38","first-page":"1122","volume-title":"Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: A retrospective comparative study in China","author":"Yang","year":"2009","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-39","first-page":"203","volume-title":"Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients","author":"Kim","year":"2012","journal-title":"Korean J Intern Med"},{"key":"key-10.4103\/0378-6323.191134-40","first-page":"1197","volume-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.191134-41","doi-asserted-by":"crossref","unstructured":"Araki Y, Sotozono C, Inatomi T, Ueta M, Yokoi N, Ueda E, et al. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 2009;147:1004-11, 1011.e1.","DOI":"10.1016\/j.ajo.2008.12.040"},{"key":"key-10.4103\/0378-6323.191134-42","first-page":"601","volume-title":"Improved treatment of the Stevens-Johnson syndrome","author":"Marvin","year":"1984","journal-title":"Arch Surg"},{"key":"key-10.4103\/0378-6323.191134-43","first-page":"27","volume-title":"Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: Experience with 41 cases and a hypothesis regarding pathogenesis","author":"Patterson","year":"1994","journal-title":"Ann Allergy"},{"key":"key-10.4103\/0378-6323.191134-44","first-page":"101","volume-title":"Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: A total series of 67 cases","author":"Tripathi","year":"2000","journal-title":"Allergy Asthma Proc"},{"key":"key-10.4103\/0378-6323.191134-45","first-page":"1339","volume-title":"Severe cutaneous adverse reactions in a local hospital setting: A 5-year retrospective study","author":"Su","year":"2014","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-46","first-page":"144","volume-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.191134-47","first-page":"90","volume-title":"Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children","author":"Kakourou","year":"1997","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/0378-6323.191134-48","first-page":"496","volume-title":"Methylprednisolone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis: Clinical evaluation and analysis of biomarkers","author":"Hirahara","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-49","first-page":"87","volume-title":"High-dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme","author":"Martinez","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0378-6323.191134-50","first-page":"523","volume-title":"Toxic epidermal necrolysis","author":"Pasricha","year":"1996","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-51","first-page":"493","volume-title":"Corticosteroids in toxic epidermal necrolysis","author":"Pasricha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-52","first-page":"270","volume-title":"Systemic corticosteroids in toxic epidermal necrolysis","author":"Dhar","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-53","first-page":"493","volume-title":"Corticosteroids in toxic epidermal necrolysis","author":"Pasricha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-54","first-page":"191","volume-title":"A six month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in Kolkata","author":"Das","year":"2013","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-55","first-page":"263","volume-title":"Suprapharmacologic doses of intravenous dexamethasone followed by cyclosporine in the treatment of toxic epidermal necrolysis","author":"Rai","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-56","first-page":"1475","volume-title":"Management of acquired bullous skin diseases","author":"Fine","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.191134-57","unstructured":"Chrousos GP. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, editor. Basic and Clinical Pharmacology. 9th ed. New York: Lange Medical Books\/McGraw-Hill; 2004. p. 641-60."},{"key":"key-10.4103\/0378-6323.191134-58","first-page":"473","volume-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","author":"Ar\u00e9valo","year":"2000","journal-title":"J Trauma"},{"key":"key-10.4103\/0378-6323.191134-59","first-page":"659","volume-title":"Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone","author":"Aihara","year":"2007","journal-title":"Pediatr Int"},{"key":"key-10.4103\/0378-6323.191134-60","first-page":"90","volume-title":"Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate","author":"Hashim","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.191134-61","first-page":"264","volume-title":"Toxic epidermal necrolysis treated with cyclosporin","author":"Hewitt","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.191134-62","first-page":"24","volume-title":"Cyclosporine for SJS\/TEN: A case series and review of the literature","author":"Reese","year":"2011","journal-title":"Cutis"},{"key":"key-10.4103\/0378-6323.191134-63","first-page":"441","volume-title":"Drug-induced toxic epidermal necrolysis treated with cyclosporin","author":"Renfro","year":"1989","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-64","first-page":"686","volume-title":"Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid","author":"Singh","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-65","first-page":"323","volume-title":"Cyclophosphamide-induced toxic epidermal necrolysis: Vigilance needed","author":"Patel","year":"2014","journal-title":"Clin Kidney J"},{"key":"key-10.4103\/0378-6323.191134-66","first-page":"847","volume-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-67","first-page":"941","volume-title":"Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine","author":"Kirchhof","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-68","first-page":"490","volume-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","author":"Viard","year":"1998","journal-title":"Science"},{"key":"key-10.4103\/0378-6323.191134-69","first-page":"26","volume-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: Multicenter retrospective analysis of 48 consecutive cases","author":"Prins","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-70","first-page":"39","volume-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience","author":"Trent","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-71","first-page":"847","volume-title":"Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis","author":"Al-Mutairi","year":"2004","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-72","first-page":"45","volume-title":"Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: Our experience","author":"Stella","year":"2001","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.191134-73","first-page":"398","volume-title":"Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: An open uncontrolled study","author":"Mangla","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-74","first-page":"81","volume-title":"Toxic epidermal necrolysis: Does immunoglobulin make a difference?","author":"Brown","year":"2004","journal-title":"J Burn Care Rehabil"},{"key":"key-10.4103\/0378-6323.191134-75","first-page":"246","volume-title":"Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis","author":"Shortt","year":"2004","journal-title":"J Burn Care Rehabil"},{"key":"key-10.4103\/0378-6323.191134-76","first-page":"33","volume-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-77","first-page":"1304","volume-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: A retrospective analysis of 64 patients managed in a specialized centre","author":"Lee","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-78","first-page":"424","volume-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: A systematic review and meta-analysis","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-79","first-page":"506","volume-title":"Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: A prospective comparative open-labelled study of 36 cases","author":"Jagadeesan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.191134-80","first-page":"236","volume-title":"Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy?","author":"Narita","year":"2011","journal-title":"J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-81","first-page":"357","volume-title":"The drug hypersensitivity syndrome: What is the pathogenesis?","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-82","first-page":"1548","volume-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.191134-83","first-page":"194","volume-title":"Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin","author":"Delattre","year":"1988","journal-title":"Neurology"},{"key":"key-10.4103\/0378-6323.191134-84","first-page":"458","volume-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-85","first-page":"255","volume-title":"Plasma exchange in patients with toxic epidermal necrolysis","author":"Bamichas","year":"2002","journal-title":"Ther Apher"},{"key":"key-10.4103\/0378-6323.191134-86","first-page":"1127","volume-title":"Severe bullous drug reactions treated successfully with cyclophosphamide","author":"Trautmann","year":"1998","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-87","first-page":"498","volume-title":"A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057).Canadian HIV Trials Network 057 Study Group","author":"Walmsley","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key-10.4103\/0378-6323.191134-88","first-page":"697","volume-title":"New advances in severe adverse drug reactions","author":"Revuz","year":"2001","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0378-6323.191134-89","first-page":"860","volume-title":"Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea and Westminster TEN management protocol [corrected]","author":"de","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-90","first-page":"305","volume-title":"Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis","author":"Goulden","year":"1996","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-91","first-page":"269","volume-title":"Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis \u2013 Experience with 3 patients","author":"Mahajan","year":"2013","journal-title":"Skinmed"},{"key":"key-10.4103\/0378-6323.191134-92","first-page":"1586","volume-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0378-6323.191134-93","first-page":"707","volume-title":"Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-94","first-page":"904","volume-title":"Etoricoxib-induced toxic epidermal necrolysis: Successful treatment with infliximab","author":"Kreft","year":"2010","journal-title":"J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-95","first-page":"150","volume-title":"Toxic epidermal necrolysis successfully treated with etanercept","author":"Gubinelli","year":"2009","journal-title":"J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-96","first-page":"60","volume-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: Comparison with case-control analysis","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0378-6323.191134-97","first-page":"e0135501","volume-title":"Stevens Johnson syndrome and toxic epidermal necrolysis: Maternal and foetal outcomes in twenty-two consecutive pregnant HIV infected women","author":"Knight","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0378-6323.191134-98","first-page":"816","volume-title":"Toxic epidermal necrolysis in pregnancy: Case report and review of the literature","author":"Struck","year":"2010","journal-title":"J Burn Care Res"},{"key":"key-10.4103\/0378-6323.191134-99","first-page":"851","volume-title":"Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology","author":"Niemeijer","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.4103\/0378-6323.191134-100","first-page":"283","volume-title":"Vulvovaginal involvement in toxic epidermal necrolysis: A retrospective study of 40 cases","author":"Meneux","year":"1998","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0378-6323.191134-101","first-page":"S96","volume-title":"Toxic epidermal necrolysis in a mother and fetus","author":"Rodriguez","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.191134-102","first-page":"39","volume-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.4103\/0378-6323.191134-103","first-page":"600","volume-title":"Toxic epidermal necrolysis in a pregnant, HIV-infected woman","author":"Pacheco","year":"2002","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-104","first-page":"279","volume-title":"Cyclosporin use during pregnancy","author":"Paziana","year":"2013","journal-title":"Drug Saf"},{"key":"key-10.4103\/0378-6323.191134-105","first-page":"965","volume-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A review of 10 years' experience","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"key-10.4103\/0378-6323.191134-106","first-page":"547","volume-title":"Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Mayes","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"key-10.4103\/0378-6323.191134-107","first-page":"505","volume-title":"An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children","author":"Koh","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"key-10.4103\/0378-6323.191134-108","first-page":"181","volume-title":"Erythema multiforme in children.Response to treatment with systemic corticosteroids","author":"Rasmussen","year":"1976","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.191134-109","first-page":"176","volume-title":"A burn center experience with toxic epidermal necrolysis","author":"Halebian","year":"1983","journal-title":"J Burn Care Rehabil"},{"key":"key-10.4103\/0378-6323.191134-110","first-page":"503","volume-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"key":"key-10.4103\/0378-6323.191134-111","first-page":"167","volume-title":"Drug-induced toxic epidermal necrolysis in children","author":"Jones","year":"1989","journal-title":"J Pediatr Surg"},{"key":"key-10.4103\/0378-6323.191134-112","first-page":"137","volume-title":"Burn unit treatment of acute, severe exfoliating disorders","author":"Halebian","year":"1989","journal-title":"Annu Rev Med"},{"key":"key-10.4103\/0378-6323.191134-113","first-page":"273","volume-title":", Pruitt BA Jr.Burn center care for patients with toxic epidermal necrolysis","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"key":"key-10.4103\/0378-6323.191134-114","first-page":"497","volume-title":"Management of severe toxic epidermal necrolysis in children","author":"Sheridan","year":"1999","journal-title":"J Burn Care Rehabil"},{"key":"key-10.4103\/0378-6323.191134-115","first-page":"155","volume-title":"Stevens-Johnson syndrome in children","author":"Ginsburg","year":"1982","journal-title":"Pediatr Infect Dis"},{"key":"key-10.4103\/0378-6323.191134-116","doi-asserted-by":"crossref","unstructured":"Wolf R, Davidovici BB. Severe acute adverse cutaneous drug reactions I: Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Wolf R, Davidovici BB, Parish LJ, Parish LC, editors. Emergency Dermatology. New Delhi: Cambridge University Press India Pvt. Ltd.; 2011. p. 154-67.","DOI":"10.1017\/CBO9780511778339.016"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:45:36Z","timestamp":1611917136000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/guidelines-for-the-management-of-stevens-johnson-syndrome-toxic-epidermal-necrolysis-an-indian-perspective\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"alternative-id":["191134"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.191134","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}